Gonorrhea and Chlamydia Trachomatis: Management
Über den Vortrag
Der Vortrag „Gonorrhea and Chlamydia Trachomatis: Management“ von John Fisher, MD ist Bestandteil des Kurses „Year 4 – Selective Sub-Internship“. Der Vortrag ist dabei in folgende Kapitel unterteilt:
- Gonorrhea and Chlamydia Trachomatis – Management
- Urethritis – Etiology
Quiz zum Vortrag
Antibiotic susceptibility of Neisseria gonorrhoeae is most significantly affected by which of the following?
- The population
- Time of year
- Concomitant infection with Chlamydia trachomatis
- Patient symptoms
- A positive patient history of adverse drug reactions
A previously healthy 24-year-old man is diagnosed with gonococcal urethritis based on symptoms and a urethral smear. What is the best treatment for this patient?
- A single intramuscular dose of ceftriaxone (500 mg) and seven days of oral doxycycline, 100 mg twice daily.
- A single intramuscular dose of ceftriaxone (250 mg)
- A single intramuscular dose of ceftriaxone (250 mg) and a 7-day course of oral azithromycin (1g/d)
- A 7-day course of oral azithromycin (1g/d)
- A single oral dose of azithromycin (1 g)
How long should men with infectious urethritis be instructed to refrain from sexual activity?
- At least 7 days following the therapy
- At least 14 days following the initiation of therapy
- At least 14 days following the end of therapy
- Refraining from sexual activity is not advised
Which of the following statement is MOST ACCURATE regarding managing the recent sexual partner(s) of a patient diagnosed with gonococcal urethritis?
- Treatment is recommended.
- Treatment is only recommended in symptomatic individuals
- Treatment without testing is prohibited
- No treatment is required
Diese Kurse könnten Sie interessieren
Dozent des Vortrages Gonorrhea and Chlamydia Trachomatis: Management
John Fisher, MD
Dr. John F. Fisher is a Professor of Medicine and Infectious Diseases at the Medical College of Georgia, Augusta University in the USA.
He obtained his medical degree from Virginia Commonwealth University School of Medicine in 1969. He is a Master of the American College of Physicians (MACP) and is certified by the American Board of Internal Medicine in Medicine and Infectious Diseases.
Due to his achievements, he has earned the Annual J. Willis Hurst Teaching Award, the Jane F. Deforges Excellence in Medical Education Award, and the Infectious Diseases Society of America's Clinical Teacher Award.
Within Lecturio, Dr. Fisher teaches courses on Infectious Diseases.
Kundenrezensionen
5,0 von 5 Sternen
| 5 Sterne |
|
5 |
| 4 Sterne |
|
0 |
| 3 Sterne |
|
0 |
| 2 Sterne |
|
0 |
| 1 Stern |
|
0 |
